Artesunate–amodiaquine and artemether–lumefantrine for the treatment of uncomplicated falciparum malaria in Liberia: in vivo efficacy and frequency of molecular markers

Artesunate–amodiaquine and artemether–lumefantrine for the treatment of uncomplicated falciparum malaria in Liberia: in vivo efficacy and frequency of molecular markers

Background: Artesunate–amodiaquine (ASAQ) and Artemether–lumefantrine (AL) are the recommended treatment for uncomplicated Plasmodium falciparum malaria in Liberia. Intermittent preventive treatment with sulfadoxine/pyrimethamine is also recommended for pregnant women. The therapeutic efficacy of Ar...

Full description

Bibliographic Details
Main Authors: Asinya, M. (Author), Jeuronlon, M.K (Author), Kamara, P. (Author), Koko, V.S (Author), Kollie, A. (Author), Ma, L. (Author), Menard, D. (Author), Nyansaiye, P. (Author), Parwon, S. (Author), Pratt, O.J (Author), Ringwald, P. (Author), Taweh, F. (Author), Tehmeh, L. (Author), Vonhm, B. (Author), Warsame, M. (Author)
Format: Article
Language:English
Published: BioMed Central Ltd 2022
Subjects:
Artemether–lumefantrine
Artesunate–amodiaquine
Efficacy
Liberia
Molecular markers of antimalarial drug resistance
Plasmodium falciparum
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items